Ascletis' ASC36_35FDC Demonstrated Potential for Once-Monthly to Once-Quarterly Dosing and Robust Weight-Loss in Preclinical Studies Presented at EASD 2026
HONG KONG, Oct. 2, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672,…
October 2, 2026
Discovering Indonesia Through Experiences Beyond the Ordinary
SEOUL, South Korea, Oct. 2, 2026 /PRNewswire/ — Fromgolfandwellnesstoculture,creativity and marine exploration,…
October 2, 2026
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
HANOI, Vietnam, Oct. 2, 2026 /PRNewswire/ — Vestas has been awarded contracts…
October 2, 2026
iQIYI AIGC Series "The Ferry Man" Exceeds RMB 8 Million in Revenue-Sharing as Third Instalment Debuts on October 1
BEIJING, Oct. 2, 2026 /PRNewswire/ — iQIYI, China’s leading online entertainment platform, announced…
October 2, 2026
IFS Capital signs inaugural MSME loan securitisation programme
S$79 million securitisation transaction backed by a portfolio of MSME loans secured…
October 2, 2026
Prestigious universities compete in Chengdu Rowing Regatta
CHENGDU, China, Oct. 2, 2026 /PRNewswire/ — A report from Chinadaily.com.cn: The…
October 2, 2026
Autoliv strengthens safety expertise with two new members to its Research Advisory Board
STOCKHOLM, Oct. 2, 2026 /PRNewswire/ — Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb),…
October 2, 2026
Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
Late-breaking Phase III MASCOT oral presentation will characterize the clinical profile and…
